These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

131 related items for PubMed ID: 17291661

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Relationship of symptomatology, gender, and antipsychotic drug treatment with plasma homovanillic acid in schizophrenia.
    Zhang ZJ, Reynolds GP, Ramchand C, Peet M, Shah S.
    Acta Pharmacol Sin; 2001 Jan; 22(1):76-80. PubMed ID: 11730567
    [Abstract] [Full Text] [Related]

  • 3. Plasma homovanillic acid differences in clinical subgroups of first episode schizophrenic patients.
    Baeza I, Castro-Fornieles J, Deulofeu R, de la Serna E, Goti J, Salvà J, Bernardo M.
    Psychiatry Res; 2009 Jul 30; 168(2):110-8. PubMed ID: 19501918
    [Abstract] [Full Text] [Related]

  • 4. Plasma homovanillic acid levels in schizophrenic patients: correlation with negative symptoms.
    Dávila R, Zumárraga M, Basterreche N, Arrúe A, Anguiano JB.
    Psychiatry Res; 2007 May 30; 151(1-2):163-8. PubMed ID: 17434602
    [Abstract] [Full Text] [Related]

  • 5. Plasma homovanillic acid levels and therapeutic outcome in schizophrenics: comparisons of neuroleptic-naive first-episode patients and patients with disease exacerbation due to neuroleptic discontinuance.
    Akiyama K, Tsuchida K, Kanzaki A, Ujike H, Hamamura T, Kondo K, Mutoh S, Miyanagi K, Kuroda S, Otsuki S.
    Biol Psychiatry; 1995 Nov 15; 38(10):639-48. PubMed ID: 8555375
    [Abstract] [Full Text] [Related]

  • 6. Plasma homovanillic acid in schizophrenics: supportive evidence for the two-subtype hypothesis.
    Chen TY, Lee CF, Lung FW, Lee TC, Lin WL, Hu WH, Yeh EK, Chang WH.
    Taiwan Yi Xue Hui Za Zhi; 1989 Jun 15; 88(6):584-8. PubMed ID: 2571672
    [Abstract] [Full Text] [Related]

  • 7. Plasma HVA in psychiatric patients: longitudinal studies.
    Javaid JI, Sharma RP, Janicak PG, Davis JM.
    Psychopharmacol Bull; 1990 Jun 15; 26(3):361-5. PubMed ID: 2274637
    [Abstract] [Full Text] [Related]

  • 8. Lack of effect of laboratory-provoked anxiety on plasma homovanillic acid concentration in normal subjects.
    Zemishlany Z, Davidson M.
    Biol Psychiatry; 1996 Aug 15; 40(4):247-52. PubMed ID: 8871770
    [Abstract] [Full Text] [Related]

  • 9. Changes in plasma glycine, L-serine, and D-serine levels in patients with schizophrenia as their clinical symptoms improve: results from the Juntendo University Schizophrenia Projects (JUSP).
    Ohnuma T, Sakai Y, Maeshima H, Hatano T, Hanzawa R, Abe S, Kida S, Shibata N, Suzuki T, Arai H.
    Prog Neuropsychopharmacol Biol Psychiatry; 2008 Dec 12; 32(8):1905-12. PubMed ID: 18835577
    [Abstract] [Full Text] [Related]

  • 10. Variability of plasma homovanillic acid over 13 months in patients with schizophrenia; relationship with the clinical response and the Wisconsin card sort test.
    Zumárraga M, González-Torres MA, Arrue A, Dávila R, Dávila W, Inchausti L, Pérez-Cabeza L, Fernández-Rivas A, Bustamante S, Basterreche N, Guimón J.
    Neurochem Res; 2011 Aug 12; 36(8):1336-43. PubMed ID: 21475956
    [Abstract] [Full Text] [Related]

  • 11. Plasma homovanillic acid levels in first-episode schizophrenia. Psychopathology and treatment response.
    Koreen AR, Lieberman J, Alvir J, Mayerhoff D, Loebel A, Chakos M, Amin F, Cooper T.
    Arch Gen Psychiatry; 1994 Feb 12; 51(2):132-8. PubMed ID: 7905259
    [Abstract] [Full Text] [Related]

  • 12. Differential effects of mental stress on plasma homovanillic acid in schizophrenia and normal controls.
    Sumiyoshi T, Saitoh O, Yotsutsuji T, Itoh H, Kurokawa K, Kurachi M.
    Neuropsychopharmacology; 1999 Apr 12; 20(4):365-9. PubMed ID: 10088137
    [Abstract] [Full Text] [Related]

  • 13. Plasma homocysteine levels in young male patients in the exacerbation and remission phase of schizophrenia.
    Petronijević ND, Radonjić NV, Ivković MD, Marinković D, Piperski VD, Duricić BM, Paunović VR.
    Prog Neuropsychopharmacol Biol Psychiatry; 2008 Dec 12; 32(8):1921-6. PubMed ID: 18824063
    [Abstract] [Full Text] [Related]

  • 14. Increments in plasma homovanillic acid concentrations after neuroleptic discontinuation are associated with worsening of schizophrenic symptoms.
    Khan RS, Amin F, Powchik P, Knott P, Goldstein M, Apter S, Kerman B, Jaff S, Davidson M.
    Prog Neuropsychopharmacol Biol Psychiatry; 1990 Dec 12; 14(6):879-84. PubMed ID: 1980541
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Prediction of short-term changes in symptom severity by baseline plasma homovanillic acid levels in schizophrenic patients receiving clozapine.
    Sumiyoshi T, Hasegawa M, Jayathilake K, Meltzer HY.
    Psychiatry Res; 1997 Mar 24; 69(2-3):113-21. PubMed ID: 9109179
    [Abstract] [Full Text] [Related]

  • 19. Effects of debrisoquin and haloperidol on plasma homovanillic acid concentration in schizophrenic patients.
    Davidson M, Losonczy MF, Mohs RC, Lesser JC, Powchik P, Freed LB, Davis BM, Mykytyn VV, Davis KL.
    Neuropsychopharmacology; 1987 Dec 24; 1(1):17-23. PubMed ID: 3509064
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.